Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

8.19
+0.63008.33%
Post-market: 8.03-0.1600-1.95%19:31 EDT
Volume:510.93K
Turnover:4.17M
Market Cap:111.38M
PE:-2.05
High:8.60
Open:7.63
Low:7.47
Close:7.56
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:12.01M
Volume Ratio:1.01
T/O Rate:4.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:0.87
PE(LYR):-1.31

Loading ...

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
May 06

Immunic Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Immunic attends Bio€quity Europe investor conference in May

Reuters
·
Apr 30

Immunic price target adjusted to $22 from $5 at H.C. Wainwright

TIPRANKS
·
Apr 30

Immunic files Form 3 for Chief Medical Officer Michael A. Panzara

Reuters
·
Apr 29

Immunic names Michael Panzara chief medical officer, replacing Andreas Muehler

Reuters
·
Apr 28

BRIEF-Immunic Appoints Biopharmaceutical Executive Michael Panzara As Chief Medical Officer

Reuters
·
Apr 28

Immunic Appoints Accomplished Biopharmaceutical Executive Michael a. Panzara, M.d., M.p.h., as Chief Medical Officer

THOMSON REUTERS
·
Apr 28

Press Release: Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Dow Jones
·
Apr 28

Immunic trading halted, news pending

TIPRANKS
·
Apr 25

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Apr 25

Immunic effects 1-for-10 reverse stock split April 27

Reuters
·
Apr 23

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS
·
Apr 23

Immunic Buy Rating: Vidofludimus Calcium’s Differentiated Efficacy and Safety Profile vs. BTK Inhibitors in Relapsing MS

TIPRANKS
·
Apr 23

Okta, Immunic, FirstEnergy, ADC, GNL Trending With Analysts

TIPRANKS
·
Apr 18

Immunic's Next-Gen Oral Multiple Sclerosis Drug Poised To Capture Share, Analyst Says

Benzinga_recent_news
·
Apr 18

Stifel Nicolaus Initiates Coverage on Immunic With Buy Rating, $2.50 Price Target

MT Newswires Live
·
Apr 17

Immunic initiated with a Buy at Stifel

TIPRANKS
·
Apr 17

Immunic Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
Apr 15

Immunic Sets 1-for-10 Reverse Stock Split Plan

TIPRANKS
·
Apr 15